Retained Earnings (Accumulated Deficit) in CNY of Gracell Biotechnologies Inc. from Q4 2019 to Q2 2023

Taxonomy & unit: us-gaap: USD and CNY
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: Gracell Biotechnologies Inc. quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2019 to Q2 2023.
Gracell Biotechnologies Inc. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Jun 2023 was -¥1.92B, a 45.5% decline year-over-year.

Retained Earnings (Accumulated Deficit), Quarterly (CNY)

Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Gracell Biotechnologies Inc. Quarterly Retained Earnings (Accumulated Deficit) (CNY)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	-1.92B	-601M	-45.5%	30 Jun 2023	6-K	14 Aug 2023
Q4 2022	-1.63B	-608M	-59.7%	31 Dec 2022	6-K	14 Aug 2023
Q2 2022	-1.32B			30 Jun 2022	6-K	15 Aug 2022
Q4 2021	-1.02B	-454M	-80.4%	31 Dec 2021	20-F	25 Apr 2023
Q4 2020	-564M	-275M	-94.9%	31 Dec 2020	20-F	22 Apr 2022
Q4 2019	-289M			31 Dec 2019	20-F	23 Apr 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.